Getagraph.com logo
S&P 500
(0.26%) 5 113.41 points
Dow Jones
(0.34%) 38 369 points
Nasdaq
(0.33%) 15 980 points
Oil
(-1.47%) $82.62
Gas
(5.36%) $2.03
Gold
(0.32%) $2 354.60
Silver
(0.14%) $27.57
Platinum
(3.96%) $958.60
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.35%) $10.99
USD/GBP
(-0.53%) $0.796
USD/RUB
(1.68%) $93.41

Echtzeitaktualisierungen für NeuroMetrix Inc [NURO]

Börse: NASDAQ Sektor: Healthcare Industrie: Medical Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 14.14%

Zuletzt aktualisiert29 Apr 2024 @ 20:06
25% discount on Stockinvest.us - Use code: Podcast

1.61% $ 4.51

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:06):

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...

Stats
Tagesvolumen 7 667.00
Durchschnittsvolumen 50 182.00
Marktkapitalisierung 8.96M
EPS $0 ( 2024-02-22 )
Nächstes Ertragsdatum ( $0 ) 2024-05-01
Last Dividend $1 728.00 ( 2007-03-28 )
Next Dividend $0 ( N/A )
P/E -0.720
ATR14 $0.0400 (0.89%)
Insider Trading
Date Person Action Amount type
2024-04-18 Horowitz Joshua Buy 16 438 Common Stock
2024-04-18 Horowitz Joshua Buy 0 Common Stock
2024-04-18 Horowitz Joshua Sell 0 Common Stock
2024-04-01 Higgins Thomas T Buy 469 Common Stock
2024-04-01 Higgins Thomas T Sell 74 Common Stock
INSIDER POWER
54.21
Last 97 transactions
Buy: 971 558 | Sell: 254 579

NeuroMetrix Inc Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

NeuroMetrix Inc Finanzdaten

Annual 2023
Umsatz: $5.90M
Bruttogewinn: $3.95M (66.89 %)
EPS: $-6.27
FY 2023
Umsatz: $5.90M
Bruttogewinn: $3.95M (66.89 %)
EPS: $-6.27
FY 2022
Umsatz: $8.26M
Bruttogewinn: $5.75M (69.65 %)
EPS: $-4.90
FY 2021
Umsatz: $8.25M
Bruttogewinn: $5.92M (71.75 %)
EPS: $-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1 728.00 2007-03-28
Last Dividend $1 728.00 2007-03-28
Next Dividend $0 N/A
Payout Date 2007-04-13
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1 728.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2007 $1.000 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.0831.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2981.200-9.95-10.00[0 - 0.3]
returnOnEquityTTM-0.3071.500-4.52-6.78[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM16.810.80010.008.00[1 - 3]
quickRatioTTM14.920.80010.008.00[0.8 - 2.5]
cashRatioTTM1.3961.5003.365.03[0.2 - 2]
debtRatioTTM0.0112-1.5009.81-10.00[0 - 0.6]
interestCoverageTTM52.631.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
freeCashFlowPerShareTTM-4.112.00-2.06-4.11[0 - 20]
debtEquityRatioTTM0.0120-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.6691.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM-1.2121.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-25.261.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.2750.800-1.497-1.198[0.5 - 2]
Total Score-0.253

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.0591.000-0.2080[1 - 100]
returnOnEquityTTM-0.3072.50-2.90-6.78[0.1 - 1.5]
freeCashFlowPerShareTTM-4.112.00-1.370-4.11[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03611.500-3.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-1.0311.000-10.000[0.1 - 0.5]
Total Score-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.